Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus

Journal of Virology

Volumn 81, Issue 11, 2007, Pages 5749-5758

  Brandsma, Janet L ^a,b   Shylankevich, Mark ^a   Su, Yuhua ^a   Roberts, Anjeanette ^b   Rose, John K ^a,b   Zelterman, Daniel ^a,b   Buonocore, Linda ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GLYCOPROTEIN E1; RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS E2 PROTEIN; VIRUS E7 PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; BINDING COMPETITION; CELLULAR IMMUNITY; CONTROLLED STUDY; COTTONTAIL RABBIT PAPILLOMAVIRUS; DISEASE ASSOCIATION; DRUG EFFICACY; HIGH RISK PATIENT; HUMORAL IMMUNITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; STOMATITIS; VACCINATION; VESICULAR STOMATITIS VIRUS;

ANIMALS; CELL LINE; COTTONTAIL RABBIT PAPILLOMAVIRUS; FEMALE; GUINEA PIGS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; RABBITS; TRANSCRIPTION FACTORS; VACCINES, SYNTHETIC; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL PROTEINS; VIRAL VACCINES;

ANIMALIA; COTTONTAIL RABBIT PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; ORYCTOLAGUS CUNICULUS; VESICULAR STOMATITIS VIRUS;

EID: 34249784248     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02835-06     Document Type: Article

References (42)

1. Aaitonen, L. M., H. Rihkanen, and A. Vaheri. 2002. Human papillomavirus in larynx. Laryngoscope 112:700-707.
2. Ahmed, A. M., V. Madkan, and S. K. Tyring. 2006. Human papillomaviruses and genital disease. Dermatol. Clin. 24:157-165.
3. Brandsma, J. L., M. Shlyankevich, L. Buonocore, A. Roberts, S. M. Becker, and J. K. Rose. 2007. Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits. Vaccine 25:751-762.
4. Brandsma, J. L., M. Shlyankevich, L. Zhang, M. D. Slade, E. C. Goodwin, W. Peh, and A. B. Deisseroth. 2004. Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection. J. Virol. 78:116-123.
5. Brunner, E., U. Munzel, and M. L. Puri. 1999. Rank-score tests in factorial designs with repeated measures. J. Multivar. Anal. 70:286-317.
6. Foley, H. D., J. P. McGettigan, C. A. Siler, B. Dietzschold, and M. J. Schnell. 2000. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA 97:14680-14685.
7. Gillison, M. L., and K. V. Shah. 2003. Chapter 9: role of mucosal human papillomavirus in nongenital cancers. J. Natl. Cancer Inst. Monogr. 2003:57-65.
8. + T-cell response to human immunodeficiency virus type 1 Gag and Env generated by vaccination with recombinant vesicular stomatitis viruses. J. Virol. 76:2730-2738.
9. Han, R., F. Breitburd, P. N. Marche, and G. Orth. 1992. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 356:66-68.
10. Han, R., N. M. Cladel, C. A. Reed, X. Peng, and N. D. Christensen. 1999. Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes. J. Virol. 73:7039-7043.
11. Han, R., X. Peng, C. A. Reed, N. M. Cladel, L. R. Budgeon, M. D. Pickel, and N. D. Christensen. 2002. Gene gun-mediated intracutaneous vaccination with papillomavirus E7 gene delays cancer development of papillomavirus-induced skin papillomas on rabbits. Cancer Detect. Prev. 26:458-467.
12. Harper, D. M., E. L. Franco, C. M. Wheeler, A.-B. Moscicki, B. Romanowski, C. M. Roteli-Martins, D. Jenkins, A. Schuind, S. A. Costa Clemens, G. Dubin, and the HPV Vaccine Study Group. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367:1247-1255.
13. Harvrood, C. A., and C. M. Proby. 2002. Human papillomaviruses and non-melanoma skin cancer. Curr. Opin. Infect. Dis. 15:101-114.
14. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
15. Jensen, E. R., R. Selvakumar, H. Shen, R. Ahmed, F. O. Wettstein, and J. F. Miller. 1997. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA. J. Virol. 71:8467-8474.
16. Jin, X., M. A. Demoitie, S. M. Donahoe, G. S. Ogg, S. Bonhoeffer, W. M. Kakimoto, G. Gillespie, P. A. Moss, W. Dyer, M. G. Kurilla, S. R. Riddell, J. Downie, J. S. Sullivan, A. J. McMichael, C. Workman, and D. F. Nixon. 2000. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. J. Infect. Dis. 181:165-175.
17. Johnston, K. B., J. M. Monteiro, L. D. Schultz, L. Chen, F. Wang, V. A. Ausensi, E. C. Dell, E. B. Santos, R. A. Moore, T. J. Palker, M. A. Stanley, and K. U. Jansen. 2005. Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes. Virology 336:208-218.
18. Kahn, J. S., A. Roberts, C. Weibel, L. Buonocore, and J. K. Rose. 2001. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. J. Virol. 75:11079-11087.
19. Kedl, R. M., W. A. Rees, D. A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, and P. Marrack. 2000. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192:1105-1113.
20. Lawson, N. D., E. A. Stillman, M. A. Whitt, and J. K. Rose. 1995. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA 92:4477-4481. (Erratum, 92:9009, 1995.)
21. Leachman, S. A., M. Shyiankevich, M. D. Slade, D. Levine, R. K. Sundaram, W. Xiao, M. Bryan, D. Zeiterman, R. E. Tiegelaar, and J. L. Brandsma. 2002. Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines. J. Virol. 76:7616-7624.
22. McMurray, H. R., D. Nguyen, T. F. Westbrook, and D. J. McAnce. 2001. Biology of human papillomaviruses. Int. J. Exp. Pathol. 82:15-33.
23. Puscas, L. 2005. The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma. Curr. Opin. Otolaryngol. Head Neck Surg. 13:212-216.
24. Ramsburg, E., N. F. Rose, P. A. Marx, M. Mefford, D. F. Nixon, W. J. Moretto, D. Montefiori, P. Earl, B. Moss, and J. K. Rose. 2004. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. J. Virol. 78:3930-3940.
25. Reuter, J. D., B. E. Vivas-Gonzalez, D. Gomez, J. H. Wilson, J. L. Brandsma, H. L. Greenstone, J. K. Rose, and A. Roberts. 2002. Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease. J. Virol. 76:8900-8909.
26. Roberts, A., L. Buonocore, R. Price, J. Forman, and J. K. Rose. 1999. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73:3723-3732.
27. Roberts, A., E. Kretzschmar, A. S. Perkins, J. Forman, R. Price, L. Buonocore, Y. Kawaoka, and J. K. Rose. 1998. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:4704-4711.
28. Roberts, A., J. D. Reuter, J. H. Wilson, S. Baldwin, and J. K. Rose. 2004. Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein. J. Virol. 78:3196-3199.
29. Roden, R. B. S., M. Ling, and T. C. Wu. 2004. Vaccination to prevent and treat cervical cancer. Hum. Pathol. 35:971-982.
30. Rose, J. K., and M. A. Whitt. 2001. Rhabdoviridae: the viruses and their replication, p. 1221-1240. In B. N. Fields and D. M. Knipe (ed.), Field's virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
31. Rose, N. F., P. A. Marx, A. Luckay, D. F. Nixon, W. J. Moretto, S. M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, and J. K. Rose. 2001. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539-549.
32. Rous, P., J. G. Kidd, and J. W. Beard. 1936. Observations on the relation of the virus causing rabbit papillomas to the cancers deriving therefrom. 1. The influence of the host species and of the pathogenic activity and concentration of the virus. J. Exp. Med. 64:385-400.
33. Saul, A., G. Lawrence, A. Smillie, C. M. Rzepczyk, C. Reed, D. Taylor, K. Anderson, A. Stowers, R. Kemp, A. Allworth, R. F. Anders, G. V. Brown, D. Pye, P. Schoofs, D. O. Irving, S. L. Dyer, G. C. Woodrow, W. R. Briggs, R. Reber, and D. Sturchler. 1999. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine 17:3145-3159.
34. Schlereth, B., J. K. Rose, L. Buonocore, V. ter Meulen, and S. Niewiesk. 2000. Successful vaccine-induced seroconversion by singlc-dosc immunization in the presence of measles virus-specific maternal antibodies. J. Virol. 74:4652-4657.
35. Seiler, P., M. A. Brundler, C. Zimmermann, D. Weibel, M. Bruns, H. Hengartner, and R. M. Zinkernagel. 1998. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization. J. Exp. Med. 187:649-654.
36. Selvakumar, R., L. A. Borenstein, Y. L. Lin, R. Ahmed, and F. O. Wettstein. 1995. Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J. Virol. 69:602-605.
37. Stanley, M. A. 2003. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection. Expert Rev. Vaccines 2:381-389.
38. Sundaram, P., and J. L. Brandsma. 1996. Rapid, efficient, large-scale purification of unfused, non-denatured E7 protein of cottontail rabbit papillomavirus. J. Virol. Methods 57:61-70.
39. Sundaram, P., R. E. Tigelaar, and J. L. Brandsma. 1997. Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge. Vaccine 15:664-671. (Erratum, 16:655, 1998.)
40. Sundaram, P., R. E. Tigelaar, W. Xiao, and J. L. Brandsma. 1998. Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge. Vaccine 16:613-623.
41. Tsang, K. Y., C. Palena, J. Yokokawa, P. M. Arlen, J. L. Gulley, G. P. Mazzara, L. Gritz, A. G. Yafal, S. Ogueta, P. Greenhalgh, K. Manson, D. Panicali, and J. Schlom. 2005. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin. Cancer Res. 11:1597-1607.
42. Wettstein, F. O., and J. G. Stevens. 1980. Distribution and state of viral nucleic acid in tumors induced by Shope papilloma virus, p. 301-307. In M. Essex, G. Todaro, and H. zur Hausen (ed.), Viruses in naturally occurring cancers, vol. 7. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.